Paying cash from the makers on November 16, 2026, Wegovy (semaglutide, for weight loss) is $349 a month at NovoCare and Mounjaro (tirzepatide, for type 2 diabetes) is $499 a month at every dose at LillyDirect. Mounjaro is not approved for weight loss, so a plan that pays for it usually needs a type 2 diabetes diagnosis; the same medicine approved for weight loss is Zepbound, from $299.
No insurance needed. Two programs to check.
Eden$99 a monthWeight loss warranty includedCheck price →
Collective$59 a month, drug priceLowest price on our chartCheck price →
These two get compared because both took off a lot of weight in clinical trials. They answer different questions at the pharmacy, though: one is a weight loss drug and the other a diabetes drug, and that decides who pays.
Wegovy vs Mounjaro, side by side
| Wegovy | Mounjaro |
|---|---|
| Medicine | |
| Semaglutide | Tirzepatide |
| Sold for cash by | |
| NovoCare (Novo Nordisk) | LillyDirect (Eli Lilly) |
| Approved for | |
| Weight loss. Also lowers heart risk in people with heart disease, and treats a fatty liver disease (MASH) | Type 2 diabetes, in adults and children 10 and older. Also lowers the risk of heart attack and stroke in adults with type 2 diabetes who are at high risk |
| Cash price | |
| $349 a month for the pen and $399 for the 7.2 mg HD pen | $499 a month |
| Form sold for cash | |
| The Wegovy pen, or the 7.2 mg HD pen | The single-dose pen |
| List price before insurance | |
| $1,349.02 a fill | $1,112.16 a fill |
| Savings card, with commercial insurance | |
| As low as $25/mo (max $100/mo off) | As low as $25 for up to a 3-month Rx (annual max $1,950), until December 31, 2026 |
| Medicare GLP-1 Bridge | |
| $50 a month | Not included |
| Doses | |
| 1.7 mg or 2.4 mg, with 2.4 mg marked recommended. Highest dose 7.2 mg weekly | No set maintenance dose. Highest dose 15 mg in adults |
Cash prices are NovoCare's and LillyDirect's own, checked November 16, 2026. You need a prescription for either.
What each costs without insurance
NovoCare sells the Wegovy pen at $349 a month from 0.25 mg to 2.4 mg and the 7.2 mg HD pen at $399. LillyDirect sells Mounjaro at $499 a month for the single-dose pen at every dose, for 28 days, up to 4 single-dose pens.
That puts Mounjaro $150 a month above the regular Wegovy pen. Full lists by dose: Wegovy cost and Mounjaro cost.
For weight loss, compare Zepbound
Mounjaro's label covers type 2 diabetes only. Its medicine, tirzepatide, is sold for weight loss as Zepbound, at $299 at 2.5 mg, $399 at 5 mg and $449 to $699 at 7.5 mg and up at LillyDirect. Someone choosing a weight loss drug is really choosing between Wegovy and Zepbound: Wegovy vs Zepbound.
In SURMOUNT-5, the one head-to-head weight loss trial, tirzepatide took off 20.2 percent of body weight on average and semaglutide 13.7 percent over 72 weeks. Why one medicine carries two names: Mounjaro vs Zepbound.
Who pays for which
A plan pays for Mounjaro when you have type 2 diabetes, often after prior approval. Without diabetes, a Mounjaro prescription for weight loss is off-label and plans rarely cover it.
A plan pays for Wegovy only where it covers weight loss, or for its heart and fatty liver uses. Prior approval is common.
Both makers have a savings card for people with commercial insurance that covers the drug. Wegovy's terms read as low as $25/mo (max $100/mo off). Mounjaro's read as low as $25 for up to a 3-month Rx (annual max $1,950), until December 31, 2026. Neither works with Medicare or Medicaid.
Medicare
The Medicare GLP-1 Bridge charges $50 a month for Wegovy to Part D members who qualify, from July 1, 2026 to December 31, 2027. Mounjaro is not on the Bridge list, and people with type 2 diabetes are outside the Bridge. Medicare says their Part D plan might cover the drug instead.
From January 1, 2027, Wegovy gets a $274 Medicare negotiated price for a 30-day supply. That is the plan's price, not your copay.
Questions people ask
Is Wegovy cheaper than Mounjaro?
Can I take Mounjaro for weight loss?
Are Wegovy and Mounjaro the same drug?
Does Medicare cover Wegovy or Mounjaro?
Compare other GLP-1 medications
- Ozempic vs Wegovy
- Ozempic vs Mounjaro
- Zepbound vs Ozempic
- Foundayo vs the Wegovy pill
- Tirzepatide vs semaglutide
- Mounjaro vs Zepbound
- Wegovy vs Zepbound
- Is there a generic GLP-1?
- Every GLP-1 medication side by side
- Wegovy cost and Mounjaro cost
Sources
Evidence checked November 15, 2026
Every figure above is taken from the document beside it, the FDA label or the trial that produced it, so you can read the source instead of trusting us. How we check sources.
7 documents
- What Wegovy is approved for and its dosesFDA prescribing information for Wegovy, injection and tablets (DailyMed, revised June 2026)
- What Mounjaro is approved for and its dosesFDA prescribing information for Mounjaro (DailyMed, revised August 2026)
- SURMOUNT-5: tirzepatide against semaglutide in 751 adults with obesity and no type 2 diabetes, 20.2 percent against 13.7 percent of body weight at 72 weeksAronne LJ et al. N Engl J Med 2025;393(1):26-36 (PubMed 40353578)
- Mounjaro's list price for one fill, before insurance or discountsMounjaro cost information (Eli Lilly)
- Which GLP-1 drugs the Medicare GLP-1 Bridge covers, who qualifies and who is outside itWeight loss drugs (Medicare.gov)
- The Bridge's $50 copay and its dates, July 1, 2026 to December 31, 2027Medicare GLP-1 Bridge (CMS)
- Wegovy's $274 Medicare negotiated price for a 30-day supply from January 1, 2027CMS fact sheet on 2027 negotiated prices
Prices from NovoCare, LillyDirect and the makers' savings card and list price pages, checked November 16. How we check prices.